Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥2.27T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥1.16T2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥3.98T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.89T2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥956.8bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥118.4bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥50.3bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥153.1bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥66.1bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥122.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥46.9bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥290.4bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥147.2bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥61.9bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥73.9bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥29.1bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥177.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥85.2bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥35.2bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥91.5bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥38.2bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥209.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥101.9bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥42.7bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥6.00Tat 2022-09-30Cons.Assets IFRS
Total assets¥5.57Tat 2022-03-31Cons.Assets IFRS
Total assets¥5.32Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.96Tat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥3.73Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥2.04Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥1.84Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.67Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥1.57Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.63Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.46Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.32Tat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥253.7bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥245.8bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥257.7bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥349.6bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥93.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥346.9bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥166.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥117.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥128.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥107.5bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥15.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥336.3bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥151.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥52.022022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥20.442022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥124.682021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥59.942021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥24.82021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥49.792022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥19.582022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥115.032021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥55.132021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥22.822021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio27.1%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio26.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.8%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥205.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥108.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥96.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30¥6.6bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥152.9bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥152.9bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥6.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue2022-04-01 → 2022-09-30¥771.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue external2022-04-01 → 2022-09-30¥745.4bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥26.0bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentsegment profit2022-04-01 → 2022-09-30¥22.7bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥212.3bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥212.0bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥309m
jpcrp040300-q2r_E00808-000Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥3.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2022-04-01 → 2022-09-30¥573.7bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2022-04-01 → 2022-09-30¥569.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2022-04-01 → 2022-09-30¥54.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue2022-04-01 → 2022-09-30¥659.7bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue external2022-04-01 → 2022-09-30¥634.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥25.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentsegment profit2022-04-01 → 2022-09-30¥42.3bn
—segment totalrevenue2022-04-01 → 2022-09-30¥2.22T
—segment totalrevenue external2022-04-01 → 2022-09-30¥2.16T
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥56.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥122.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥2.42T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥2.27T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥152.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥129.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥172.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥81.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥90.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30¥6.1bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥140.6bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥140.6bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥7.3bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue2021-04-01 → 2021-09-30¥614.8bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue external2021-04-01 → 2021-09-30¥593.9bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥20.9bn
jpcrp040300-q2r_E00808-000Chemicalsreportable segmentsegment profit2021-04-01 → 2021-09-30¥62.2bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue2021-04-01 → 2021-09-30¥198.7bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue external2021-04-01 → 2021-09-30¥198.5bn
jpcrp040300-q2r_E00808-000Health Carereportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥171m
jpcrp040300-q2r_E00808-000Health Carereportable segmentsegment profit2021-04-01 → 2021-09-30¥1.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2021-04-01 → 2021-09-30¥447.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2021-04-01 → 2021-09-30¥444.1bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2021-04-01 → 2021-09-30¥48.3bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue2021-04-01 → 2021-09-30¥592.2bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue external2021-04-01 → 2021-09-30¥566.7bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥25.5bn
jpcrp040300-q2r_E00808-000Performance Productsreportable segmentsegment profit2021-04-01 → 2021-09-30¥45.8bn
—segment totalrevenue2021-04-01 → 2021-09-30¥1.85T
—segment totalrevenue external2021-04-01 → 2021-09-30¥1.80T
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥49.8bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥157.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥2.03T
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥1.89T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥140.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥163.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 950
ItemContextValueUnit
Gain on sale of investments in subsidiaries and associates ope cf IFRSPrior1YTDDuration-1886000000JPY
Gain on sale of investments in subsidiaries and associates ope cf IFRSCurrentYTDDuration-5000000JPY
Interest and dividend income ope cf IFRSPrior1YTDDuration-4610000000JPY
Interest and dividend income ope cf IFRSCurrentYTDDuration-8868000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration10708000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration12405000000JPY
Decrease increase in trade receivables ope cf IFRSPrior1YTDDuration-18172000000JPY
Decrease increase in trade receivables ope cf IFRSCurrentYTDDuration-2318000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-83804000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-101945000000JPY
Increase decrease in trade payables ope cf IFRSPrior1YTDDuration32322000000JPY
Increase decrease in trade payables ope cf IFRSCurrentYTDDuration15326000000JPY
Increase or decrease in retirement benefit asset or liability ope cf IFRSPrior1YTDDuration2091000000JPY
Increase or decrease in retirement benefit asset or liability ope cf IFRSCurrentYTDDuration1732000000JPY
Other changes in working capital ope cf IFRSPrior1YTDDuration-17485000000JPY
Other changes in working capital ope cf IFRSCurrentYTDDuration-20876000000JPY
Subtotal ope cf IFRSPrior1YTDDuration187422000000JPY
Subtotal ope cf IFRSCurrentYTDDuration146657000000JPY
Interest received ope cf IFRSPrior1YTDDuration648000000JPY
Interest received ope cf IFRSCurrentYTDDuration560000000JPY
Dividends received ope cf IFRSPrior1YTDDuration9002000000JPY
Dividends received ope cf IFRSCurrentYTDDuration19344000000JPY
Interest paid ope cf IFRSPrior1YTDDuration-10681000000JPY
Interest paid ope cf IFRSCurrentYTDDuration-11113000000JPY
Income taxes refund paid ope cf IFRSPrior1YTDDuration-20092000000JPY
Income taxes refund paid ope cf IFRSCurrentYTDDuration-62237000000JPY
Net cash provided by used in operating activities IFRSPrior1YTDDuration166299000000JPY
Net cash provided by used in operating activities IFRSCurrentYTDDuration93211000000JPY
Purchase of property plant and equipment inv cf IFRSPrior1YTDDuration-111729000000JPY
Purchase of property plant and equipment inv cf IFRSCurrentYTDDuration-124863000000JPY
Proceeds from sale of property plant and equipment inv cf IFRSPrior1YTDDuration2572000000JPY
Proceeds from sale of property plant and equipment inv cf IFRSCurrentYTDDuration3065000000JPY
Purchase of intangible assets inv cf IFRSPrior1YTDDuration-5617000000JPY
Purchase of intangible assets inv cf IFRSCurrentYTDDuration-5885000000JPY
Purchase of investments inv cf IFRSPrior1YTDDuration-1927000000JPY
Purchase of investments inv cf IFRSCurrentYTDDuration-1998000000JPY
Proceeds from sale of investments inv cf IFRSPrior1YTDDuration16483000000JPY
Proceeds from sale of investments inv cf IFRSCurrentYTDDuration9814000000JPY
Payments for acquisition of subsidiaries inv cf IFRSPrior1YTDDuration-6501000000JPY
Payments for acquisition of subsidiaries inv cf IFRSCurrentYTDDuration-108000000JPY
Payments for acquisition of businesses inv cf IFRSPrior1YTDDuration-700000000JPY
Payments for acquisition of businesses inv cf IFRSCurrentYTDDuration-JPY
Proceeds from sale of businesses inv cf IFRSPrior1YTDDuration1372000000JPY
Proceeds from sale of businesses inv cf IFRSCurrentYTDDuration1934000000JPY
Net decrease increase in time deposits inv cf IFRSPrior1YTDDuration367000000JPY
Net decrease increase in time deposits inv cf IFRSCurrentYTDDuration-1063000000JPY
Other inv cf IFRSPrior1YTDDuration-1801000000JPY
Other inv cf IFRSCurrentYTDDuration1448000000JPY
Net cash provided by used in investing activities IFRSPrior1YTDDuration-107481000000JPY
Net cash provided by used in investing activities IFRSCurrentYTDDuration-117656000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass